Breaking News

You are here » Indian-Commodity  :  Corporate  :  AstraZeneca Pharma receives DCGI permission for Symbicort Turbuhaler

16-Jun2017

AstraZeneca Pharma receives DCGI permission for Symbicort Turbuhaler

AstraZeneca Pharma India has received Import and Market permission in Form 45 (Marketing Authorization) from the Drug Controller General of India (DCGI) for FDC of Budesonide 320 g +Formoterol Fumarate Dihydrate 9 g inhalation powder.

FDC of Budesonide 320 g + Formoterol Fumarate Dihydrate 9 g inhalation powder (Symbicort Turbuhaler 320/9 g) is a product of AstraZeneca global and is indicated in the regular treatment of Asthma where use of combination of inhaled regular corticosteroid & long acting β-agonist is appropriate and patients with moderate to severe COPD with frequent symptoms and a history of exacerbations.

AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The company operates through two segments Healthcare and Clinical Trial.




Related News

View all news

Allsec Technologies, Conneqt sign definitive agreements

Allsec Technologies and Conneqt Business Solutions (Conneqt), a subsidiary of Quess Corp, have signed definitive agreements. As per agreements, Conneqt will acquire a majority stake in Allsec Technologies.The......

Mindtree reports 9% rise in Q4 consolidated net profit

Mindtree has reported results for the fourth quarter and year ended March 31, 2019.  The company has reported a rise of 8.90% in its net profit at Rs 198.30 crore for the quarter ended March 31,......

Tata Motors' arm's Jaguar I-Pace wins 2019 World Car Awards

Tata Motors' Jaguar Land Rover's (JLR) luxury vehicle brand -- Jaguar I-Pace has become first model to win three World Car titles in the 15-year history of the awards. This latest win for the I-PACE, awarded......

Top News

View all news

Quess Corp, Ashoka Buildcon and ICICI Bank to see some action today

Quess Corp's subsidiary Conneqt Business Solutions has signed definitive agreements to acquire a majority stake in Allsec Technologies. The transaction involves Conneqt purchasing 35.35% from the promoters,......

Quess Corp's arm to acquire majority stake in Allsec Technologies

Quess Corp's subsidiary -- Conneqt Business Solutions has signed definitive agreements to acquire a majority stake in Allsec Technologies. The transaction involves Conneqt purchasing 35.35% from the promoters,......

Ashoka Buildcon's JV receives LoA from Rail Vikas Nigam

Ashoka Buildcon's Joint Venture (JV) -- ABL-STS JV, wherein the Company is lead member, has received a Letter of Award (LoA) from Rail Vikas Nigam (RVNL). The accepted Bid Value of the Project is Rs 443.23......